Gordon M. Saul

Medluminal Systems, Inc. develops catheters. The Company's catheter consists of a beta-active woven metal mesh that, when expanded, does not block blood flow through the coronary artery. It is located in Palo Alto, CA.

InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California.

AlgoRx Pharmaceuticals, Inc. was a pharmaceutical company. The company developed and commercialized drugs for pain management. The company was founded in 2001 and was hedquartered in Secaucus, NJ.

Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK

ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA.

Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA.

On Demand Therapeutics, Inc. develops implantable devices to enable on demand release of drugs to the back of the eye. The firm also develops small injectable ophthalmic implants containing multiple laser-activated reservoirs designed for the treatment of sight-threatening diseases of the retina. The company was founded on September 22, 2008 and is headquartered in Menlo Park, CA.

Synvascular, Inc. designed, developed, and marketed medical devices. The company was founded in 2007 and was located in Palo Alto, CA.

Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford.